Does Aetna Cover Depression Treatment in New Mexico? A 2026 Guide

Last updated: July 12, 2026

If you have Aetna insurance in New Mexico and you’re wondering whether your plan may cover depression treatment, you’re not alone. Depression is one of the most common mental health conditions in the United States, and navigating insurance coverage for antidepressants, therapy, and newer treatment options like esketamine can feel overwhelming. This guide breaks down how Aetna health plans in New Mexico typically handle depression treatment coverage in 2026, including formulary details for CVS/Caremark — Aetna’s pharmacy benefits manager — and what you may need to know about prior authorizations, parity protections, and telehealth access.

Coverage varies by plan. Always verify your specific benefits before booking an appointment.

See if your Aetna plan may cover depression treatment through Klarity Health.
Check Depression Treatment Options at Klarity →

Does Aetna Cover Depression Treatment in New Mexico?

Aetna health plans sold in New Mexico typically cover depression treatment as a core mental health benefit under both federal and state parity laws. This coverage often includes outpatient therapy visits, psychiatric evaluations, medication management, and prescription antidepressants through the CVS/Caremark formulary. Coverage levels, copays, and prior authorization requirements vary by specific plan — fully insured commercial plans, ACA Marketplace plans, and self-funded employer plans may all have different cost-sharing structures.

Under the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and New Mexico’s state parity law (NMSA 1978 § 59A-23E-19 et seq.), Aetna plans are generally required to cover mental health services — including depression treatment — on terms no more restrictive than medical and surgical benefits. This means your copay for a depression medication management visit should generally be comparable to what you’d pay for a similar primary care appointment.

CVS/Caremark Formulary: Depression Medications and Tier Placement

Aetna uses CVS/Caremark as its pharmacy benefits manager for most commercial and ACA plans in New Mexico. CVS/Caremark’s formulary is organized into tiers that determine your out-of-pocket cost at the pharmacy. For depression medications, the formulary generally follows a generic-first, step-therapy model.

First-Line Antidepressants (Generics): Tier 1–2, Typically No Prior Authorization

Generic SSRIs and SNRIs are the most commonly prescribed antidepressants and typically sit at Tier 1 or Tier 2 on the CVS/Caremark formulary, with no prior authorization required for most plans:

Tier placements are typical estimates. Confirm your specific plan’s formulary at caremark.com or by calling CVS/Caremark at 1-800-552-8159.

Newer Brand Antidepressants: Tier 3–4, Step Therapy Often Required

Branded antidepressants and newer-generation agents typically fall into Tier 3 or Tier 4, often requiring prior authorization or step therapy — meaning the plan may require a trial of a generic equivalent first. Notable examples include:

Important note on Auvelity: Auvelity is a distinct combination brand product (dextromethorphan + bupropion) — it is not the same as standard generic bupropion (Wellbutrin). Patients who are prescribed Auvelity should not assume it will be treated as a generic bupropion equivalent on their formulary. Most CVS/Caremark plans place Auvelity in a higher tier with PA requirements, separate from the generic bupropion Tier 1–2 placement.

Spravato (Esketamine): Specialty Tier, PA + REMS Required

Spravato (esketamine nasal spray) is an FDA-approved treatment for treatment-resistant depression (TRD) and major depressive disorder with acute suicidal ideation or behavior (MDDSI). On the CVS/Caremark formulary, Spravato typically sits at a specialty tier with both prior authorization and a Risk Evaluation and Mitigation Strategy (REMS) program requirement. The REMS requires that Spravato be administered in a certified healthcare setting — it cannot be taken at home — which limits its availability to specialized outpatient clinic settings.

Spravato is classified as a Schedule III controlled substance. It is not a Schedule II drug. This distinction matters for prescribing requirements — see the EPCS section below.

Electronic Prescribing of Controlled Substances (EPCS): Does It Apply to Depression Medications?

New Mexico’s EPCS law (§ 456.44 of the New Mexico Administrative Code) requires electronic prescribing for Schedule II controlled substances. This rule applies to medications like ADHD stimulants (amphetamine salts, methylphenidate) — but it does not apply to any standard antidepressant medication.

All first-line and second-line antidepressants — SSRIs, SNRIs, bupropion, mirtazapine, tricyclics, and others — are entirely non-controlled substances. There are no Schedule II antidepressants. EPCS requirements are entirely inapplicable to depression treatment prescriptions at Klarity Health or any New Mexico telehealth provider. Providers may still use electronic prescribing as a convenience and best practice, but it is not mandated for these medications.

Spravato (esketamine) is the only depression treatment with any controlled substance classification — Schedule III. However, § 456.44 EPCS applies to Schedule II only. Spravato remains exempt from the EPCS mandate. Spravato’s REMS requirement is a separate FDA drug-safety program and does not overlap with state EPCS rules.

In practical terms: patients seeking depression treatment through Aetna and CVS/Caremark-covered telehealth services in New Mexico face no EPCS-related prescribing barriers.

Prior Authorization Process for Depression Treatment Under Aetna in New Mexico

When a depression medication or service requires prior authorization, Aetna and CVS/Caremark maintain separate PA workflows:

• Pharmacy PA (prescription medications): Handled by CVS/Caremark. Your prescribing provider submits documentation (diagnosis, treatment history, clinical rationale) to CVS/Caremark at 1-800-552-8159. Standard PA review typically takes up to 72 hours; urgent situations may qualify for a 24-hour expedited review.
• Medical/behavioral health PA (therapy visits, psychiatric evaluations): Handled by Aetna directly. Contact Aetna member services at 1-800-872-3862 for behavioral health benefit verification and PA requirements for outpatient visits.

If a PA request is denied, you have the right to an internal appeal through Aetna and, if the internal appeal is unsuccessful, an external independent review. Patients covered under self-funded employer plans may also contact the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) for federal-level appeal guidance.

New Mexico Mental Health Parity and Aetna

New Mexico’s Mental Health Parity Act (NMSA 1978 § 59A-23E-19 et seq.) requires that fully insured health plans offered in New Mexico provide mental health and substance use disorder benefits on terms no more restrictive than comparable medical and surgical benefits. This parity requirement applies to Aetna’s fully insured commercial and ACA Marketplace plans in New Mexico.

Parity protections typically cover:

• Copays and coinsurance for therapy and psychiatric visits
• Prior authorization requirements — which may not be applied more broadly to mental health services than to comparable medical services
• Annual and lifetime visit limits
• Out-of-network benefit rules

ERISA carve-out: If your Aetna coverage comes through a large self-funded employer plan, New Mexico’s state parity statute may not apply directly. However, the federal MHPAEA still governs self-funded employer plans and provides similar protections. Contact the U.S. Department of Labor’s EBSA (1-866-444-3272) if you believe your employer plan’s mental health benefits are unfairly restricted.

Telehealth Coverage for Depression Through Aetna in New Mexico

New Mexico’s telehealth parity law requires that health plans cover telehealth mental health services on the same basis as equivalent in-person services. For Aetna members in New Mexico, this typically means that telehealth depression treatment appointments — including medication management and therapy delivered via video — should not carry higher cost-sharing than comparable in-person visits.

Klarity Health connects New Mexico residents with a network of 2,000+ licensed providers who specialize in depression treatment, including medication management and psychiatric care delivered via telehealth. Providers on the Klarity platform are licensed in New Mexico and can prescribe antidepressants — including SSRIs, SNRIs, and other first-line agents — where clinically appropriate.

Ready to explore depression treatment options?
See How Klarity Health Supports Depression Treatment →

What Depression Medications May Be Covered by Aetna in New Mexico?

The following categories of depression medications are typically covered by Aetna health plans through the CVS/Caremark formulary, subject to your plan’s specific cost-sharing and prior authorization requirements:

• Selective Serotonin Reuptake Inhibitors (SSRIs): Sertraline, fluoxetine, escitalopram, citalopram, paroxetine — generics typically Tier 1–2 with no PA
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine ER generic, duloxetine generic — typically Tier 1–2 with no PA; brand SNRI versions typically Tier 3–4 with step therapy
• Bupropion (generic Wellbutrin): Tier 1–2, typically no PA; also used off-label for ADHD and smoking cessation
• Mirtazapine (generic Remeron): Tier 1–2, typically no PA; often used for depression with insomnia or appetite loss
• Tricyclic antidepressants (TCAs): Amitriptyline, nortriptyline, imipramine generics — Tier 1–2, typically no PA; second-line due to side effect profile
• Trintellix (vortioxetine): Tier 3–4, PA likely required; may require generic SSRI/SNRI trial first
• Auvelity (dextromethorphan/bupropion): Tier 3–4, PA likely required; not equivalent to generic bupropion on formulary
• Spravato (esketamine): Specialty tier, PA + REMS required; for treatment-resistant depression only; must be administered in certified clinic setting

Always verify your specific plan’s formulary at caremark.com or by logging into your Aetna member portal (aetna.com) before your appointment.

Important Contacts for Aetna Depression Coverage in New Mexico

• Aetna Member Services (behavioral health PA, benefits, appeals): 1-800-872-3862
• CVS/Caremark (pharmacy PA, formulary questions): 1-800-552-8159
• New Mexico Office of the Superintendent of Insurance (OSI) — consumer complaints and appeals: 1-855-427-5674

Frequently Asked Questions

Does Aetna typically cover antidepressants in New Mexico?

In most cases, yes — Aetna health plans in New Mexico typically cover generic antidepressants at Tier 1–2 on the CVS/Caremark formulary with no prior authorization required. Brand-name antidepressants and newer agents like Trintellix or Auvelity may require prior authorization or step therapy. Your specific copay depends on your plan design and deductible status. Verify your benefits at aetna.com or by calling 1-800-872-3862.

Do Aetna plans in New Mexico require prior authorization for therapy visits?

Aetna’s requirements for behavioral health visit PA vary by plan. Some plans require a referral or PA for outpatient therapy; others allow direct access. Under New Mexico’s parity law, PA requirements for mental health visits may not be applied more restrictively than for equivalent medical visits. Call Aetna behavioral health at 1-800-872-3862 before your first appointment to confirm your plan’s specific requirements.

Does EPCS apply to antidepressant prescriptions in New Mexico?

No. New Mexico’s Electronic Prescribing of Controlled Substances (EPCS) law under § 456.44 applies only to Schedule II controlled substances. All standard antidepressants — SSRIs, SNRIs, bupropion, mirtazapine, tricyclics, and others — are entirely non-controlled substances. EPCS requirements are entirely inapplicable to depression treatment prescriptions in New Mexico. Spravato (esketamine) is Schedule III — still not subject to § 456.44, which covers Schedule II only.

What can I do if Aetna denies coverage for my depression medication?

If Aetna or CVS/Caremark denies a PA for your antidepressant, you have the right to appeal. Your prescribing provider can submit a letter of medical necessity and clinical documentation supporting the need for the specific medication. If the internal Aetna appeal is unsuccessful, you may request an external independent review. New Mexico residents on fully insured plans can also contact the NM Office of the Superintendent of Insurance at 1-855-427-5674 for assistance. Patients on self-funded employer plans can contact the U.S. Department of Labor’s EBSA at 1-866-444-3272.

Can I get depression treatment through Klarity Health if I have Aetna in New Mexico?

Klarity Health has a network of 2,000+ licensed providers, including those who specialize in depression treatment via telehealth. Whether a specific Klarity provider is in-network for your Aetna plan depends on your plan type (HMO vs. PPO) and provider credentialing. We recommend verifying in-network status and your telehealth benefit coverage at aetna.com before booking. New Mexico’s telehealth parity law means your plan typically may not charge more for telehealth depression visits than for equivalent in-person visits.

Explore depression treatment options through Klarity Health.
Learn About Depression Treatment at Klarity →

Disclaimer: This article is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage descriptions use language such as “may,” “typically,” and “often” because actual coverage varies significantly by plan. Aetna plan terms, CVS/Caremark formulary tier placements, and prior authorization requirements may change at any time. Always verify your specific benefits with Aetna (1-800-872-3862) and CVS/Caremark (1-800-552-8159) before booking an appointment or filling a prescription. Klarity Health cannot guarantee insurance coverage or reimbursement for any service.